| LABCORP HLDGS INC. O.N. |
| USA |
| Gesundheit |
| US5049221055 / A40C39 |
| N6B (Frankfurt) / LH (NYSE) |
| FRA:N6B, ETR:N6B, N6B:GR, NYSE:LH |
| - |
| https://www.labcorp.com/ |
|
Labcorp Holdings Inc. is a healthcare diagnostics and laboratory services company that supports physicians, hospitals, pharmaceutical companies, researchers, and patients with clinical testing and scientific insights. Labcorp Holdings Inc. operates t..
>Volltext.. |
| 23560.78 Mio. EUR |
| 29409.6 Mio. EUR |
| 12385.78 Mio. EUR |
| 2007.38 Mio. EUR |
| 865.23 Mio. EUR |
| 10.51 EUR |
| 5840.78 Mio. EUR |
| 122.41 Mio. EUR |
| 1414.33 Mio. EUR |
| 0.07 |
| 9.76% |
| 35.42% |
| 2.47 EUR |
| 0.86% |
| 0.85% |
| 28.08.26 - 0.617976€ 29.05.26 - 0.617976€ >weitere anzeigen... |
| 4 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 2.732.533 Euro. |
| LABCORP |
| 01.09.26 |
|